tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SRZN Stock Latest News

Surrozen files $150M mixed securities shelf
The FlySurrozen files $150M mixed securities shelf
2M ago
SRZN
Surrozen Holds Successful 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Surrozen Holds Successful 2025 Annual Stockholders Meeting
2M ago
8K
SRZN
Surrozen granted patent from USPTO directed to antibody-based molecules
PremiumThe Fly
Surrozen granted patent from USPTO directed to antibody-based molecules
2M ago
SRZN
Surrozen’s Strategic Focus on Wnt Pathway and Promising Pipeline Earns Buy Rating
PremiumRatings
Surrozen’s Strategic Focus on Wnt Pathway and Promising Pipeline Earns Buy Rating
2M ago
SRZN
Surrozen, Inc. Reports Q1 2025 Financial Results
PremiumCompany Announcements
Surrozen, Inc. Reports Q1 2025 Financial Results
2M ago
SRZN
Surrozen files to sell 5.21M shares of common stock for holders
PremiumThe FlySurrozen files to sell 5.21M shares of common stock for holders
3M ago
SRZN
Surrozen’s Strategic Shift to Ophthalmology and Wnt Pathway Innovations Justify Buy Rating
Premium
Ratings
Surrozen’s Strategic Shift to Ophthalmology and Wnt Pathway Innovations Justify Buy Rating
3M ago
SRZN
Surrozen Focuses on Ophthalmology Amid Financial Challenges
Premium
Company Announcements
Surrozen Focuses on Ophthalmology Amid Financial Challenges
3M ago
SRZN
Surrozen reports FY24 EPS ($21.67) vs. ($21.33) last year
PremiumThe Fly
Surrozen reports FY24 EPS ($21.67) vs. ($21.33) last year
3M ago
SRZN
Surrozen Secures $76.4M in Private Placement Deal
PremiumCompany Announcements
Surrozen Secures $76.4M in Private Placement Deal
4M ago
8K
SRZN
Surrozen to focus Wnt expertise, technologies on ophthalmology programs
PremiumThe Fly
Surrozen to focus Wnt expertise, technologies on ophthalmology programs
4M ago
SRZN
Surrozen to discontinue development of SZN-043 in alcohol associated hepatitis
PremiumThe Fly
Surrozen to discontinue development of SZN-043 in alcohol associated hepatitis
4M ago
SRZN
Meta Platforms, CVS Health upgraded: Wall Street’s top analyst calls
PremiumThe FlyMeta Platforms, CVS Health upgraded: Wall Street’s top analyst calls
5M ago
BL
KO
Surrozen initiated with a Buy at H.C. Wainwright
Premium
The Fly
Surrozen initiated with a Buy at H.C. Wainwright
5M ago
SRZN
Block upgraded, Bumble downgraded: Wall Street’s top analyst calls
Premium
The Fly
Block upgraded, Bumble downgraded: Wall Street’s top analyst calls
6M ago
BK
LB
Guggenheim upgrades Surrozen to Buy after ‘encouraging’ SZN-043 data
PremiumThe Fly
Guggenheim upgrades Surrozen to Buy after ‘encouraging’ SZN-043 data
6M ago
SRZN
Surrozen upgraded to Buy from Neutral at Guggenheim
PremiumThe Fly
Surrozen upgraded to Buy from Neutral at Guggenheim
6M ago
SRZN
Surrozen, Inc.: Q3 2024 Earnings Overview
PremiumCompany Announcements
Surrozen, Inc.: Q3 2024 Earnings Overview
8M ago
SRZN
Surrozen reports Q3 EPS (44c) vs. ($5.14) last year
PremiumThe Fly
Surrozen reports Q3 EPS (44c) vs. ($5.14) last year
8M ago
SRZN
Surrozen, TCGFB announce strategic research collaboration
PremiumThe FlySurrozen, TCGFB announce strategic research collaboration
8M ago
SRZN
Surrozen earns $10M milestone payment in Retinal Diseases collaboration
Premium
The Fly
Surrozen earns $10M milestone payment in Retinal Diseases collaboration
10M ago
SRZN
Surrozen Announces Tim Kutzkey’s Board Resignation
Premium
Company Announcements
Surrozen Announces Tim Kutzkey’s Board Resignation
1y ago
8K
SRZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >